78 results
Page 3 of 4
6-K
EX-99.2
yd4wyfmuis
10 Dec 20
Current report (foreign)
6:03am
6-K
EX-99.1
p3h gkxjjpun8
10 Dec 20
Current report (foreign)
6:03am
6-K
EX-99.1
z0r0tc4 dg03j1
24 Nov 20
Current report (foreign)
6:03am
6-K
EX-1.1
y4c nqmjnuyfj8
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
6cw9kqqvoegx4k
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.1
3geiezcngtky97wl7
14 Aug 20
Current report (foreign)
4:24pm
6-K
EX-99.3
1hregwiwiebe 9el03
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
vgu75toorx4etwnglx
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
rd4 euae7hebn
7 Jul 20
Current report (foreign)
3:39pm
6-K
EX-99.1
8nepisgp7 vdc3huiway
4 Jun 20
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
6:11am
6-K
EX-99.3
ltwnyf0
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
wnn 1xftv
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
ce12sa90fou nbm99
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.3
1d61k
7 Nov 19
Current report (foreign)
9:11am
F-3
EX-4.1
j74 842ylcmblfa
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
3wtax
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.3
xz9r3tlnje8qn 8gwi0
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
390py334c
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am